相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detection of Human Coronavirus NL63 and 0C43 in Children with Acute Respiratory Infections in Niigata, Japan, between 2010 and 2011
Miyako Kon et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2012)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
Inactivation of surrogate coronaviruses on hard surfaces by health care germicides
Rachel L. Hulkower et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Antiseptic properties of two calix[4]arenes derivatives on the human coronavirus 229E
C. Geller et al.
ANTIVIRAL RESEARCH (2010)
The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus
Christine Dellanno et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2009)
Coronavirus Infection and Hospitalizations for Acute Respiratory Illness in Young Children
H. Keipp B. Talbot et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
A new Sephadex™-based method for removing microbicidal and cytotoxic residues when testing antiseptics against viruses: Experiments with a human coronavirus as a model
Chloe Geller et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
The Pediatric Burden of Human Coronaviruses Evaluated for Twenty Years
H. Keipp Talbot et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Survival of surrogate coronaviruses in water
Lisa Casanova et al.
WATER RESEARCH (2009)
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
Fumihiko Yasui et al.
JOURNAL OF IMMUNOLOGY (2008)
Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France
Astrid Vabret et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2008)
Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
Kumari G. Lokugamage et al.
VACCINE (2008)
Canine coronavirus inactivation with physical and chemical agents
Annamaria Pratelli
VETERINARY JOURNAL (2008)
Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients
Giuseppe Gerna et al.
JOURNAL OF CLINICAL VIROLOGY (2007)
Impact of human coronavirus infections in otherwise healthy children who attended an emergency department
Susanna Esposito et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
Damon Deming et al.
PLOS MEDICINE (2006)
Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
Koji Ishii et al.
VIROLOGY (2006)
Molecular diversity of coronaviruses in bats
Patrick C. Y. Woo et al.
VIROLOGY (2006)
Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients
G Gerna et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design
Yuxian He et al.
JOURNAL OF VIROLOGY (2006)
A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice
ZM Zhou et al.
VACCINE (2006)
Detection of the new human coronavirus HKU1: A report of 6 cases
A Vabret et al.
CLINICAL INFECTIOUS DISEASES (2006)
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus
RH See et al.
JOURNAL OF GENERAL VIROLOGY (2006)
A double-inactivated whole virus candidate SARS coronavirus vaccine
M Spruth et al.
VACCINE (2006)
Evidence of human coronavirus HKU1 and human bocavirus in Australian children
TP Sloots et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents
H Kariwa et al.
DERMATOLOGY (2006)
Coronaviruses and their therapy
Bart L. Haagmans et al.
ANTIVIRAL RESEARCH (2006)
Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia
PCY Woo et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Immunopathogenesis of coronavirus infections: Implications for SARS
S Perlman et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Bats are natural reservoirs of SARS-like coronaviruses
WD Li et al.
SCIENCE (2005)
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
PCY Woo et al.
VACCINE (2005)
Efficacy of various disinfectants against SARS coronavirus
HF Rabenau et al.
JOURNAL OF HOSPITAL INFECTION (2005)
Survival of severe acute respiratory syndrome coronavirus
MYY Lai et al.
CLINICAL INFECTIOUS DISEASES (2005)
Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
SU Kapadia et al.
VIROLOGY (2005)
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
SKP Lau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms
B Kan et al.
JOURNAL OF VIROLOGY (2005)
Human coronavirus NL63, France
A Vabret et al.
EMERGING INFECTIOUS DISEASES (2005)
Croup is associated with the novel coronavirus NL63
L van der Hoek et al.
PLOS MEDICINE (2005)
SARS vaccine protective in mice
K Stadler et al.
EMERGING INFECTIOUS DISEASES (2005)
Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China
SS Chiu et al.
CLINICAL INFECTIOUS DISEASES (2005)
Development of antiviral therapy for severe acute respiratory syndrome
J Cinatl et al.
ANTIVIRAL RESEARCH (2005)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia
KE Arden et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region
ZW Chen et al.
JOURNAL OF VIROLOGY (2005)
Human coronavirus NL63 infection in Canada
N Bastien et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children
F Esper et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice
ZJ Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Complete genomic sequence of human coronavirus OC43:: Molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event
L Vijgen et al.
JOURNAL OF VIROLOGY (2005)
Identification of a novel coronavirus in bats
LLM Poon et al.
JOURNAL OF VIROLOGY (2005)
Stability and inactivation of SARS coronavirus
HF Rabenau et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2005)
Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
B Morgenstern et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia
PCY Woo et al.
JOURNAL OF VIROLOGY (2005)
SARS in hospital emergency room
YC Chen et al.
EMERGING INFECTIOUS DISEASES (2004)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A previously undescribed coronavirus associated with respiratory disease in humans
RAM Fouchier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Identification of a new human coronavirus
L van der Hoek et al.
NATURE MEDICINE (2004)
Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction
LJR van Elden et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Immunogenicity of SARS inactivated vaccine in BALB/c mice
S Xiong et al.
IMMUNOLOGY LETTERS (2004)
Severe acute respiratory syndrome coronavirus on hospital surfaces
SF Dowell et al.
CLINICAL INFECTIOUS DISEASES (2004)
Human respiratory coronavirus OC43: Genetic stability and neuroinvasion
JR St-Jean et al.
JOURNAL OF VIROLOGY (2004)
Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
YX He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
A Bukreyev et al.
LANCET (2004)
Severe acute respiratory syndrome-associated coronavirus in lung tissue
T Mazzulli et al.
EMERGING INFECTIOUS DISEASES (2004)
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
N Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice
L Tang et al.
DNA AND CELL BIOLOGY (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
N Takasuka et al.
INTERNATIONAL IMMUNOLOGY (2004)
DNA vaccine of SARS-Cov S gene induces antibody response in mice
P Zhao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2004)
Transmission of the severe acute respiratory syndrome on aircraft
SJ Olsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Current concepts: The severe acute respiratory syndrome
JSM Peiris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Coronavirus 229E-related pneumonia in immunocompromised patients
F Pene et al.
CLINICAL INFECTIOUS DISEASES (2003)
The SARS epidemic in Hong Kong
SH Lee
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2003)
Possible role of an animal vector in the SARS outbreak at Amoy Gardens
SKC Ng
LANCET (2003)
Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China
Z Zhao et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Transmission dynamics and control of severe acute respiratory syndrome
M Lipsitch et al.
SCIENCE (2003)
Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions
S Riley et al.
SCIENCE (2003)
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
J Cinatl et al.
LANCET (2003)
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
CM Booth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong
CA Donnelly et al.
LANCET (2003)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
A multicentre collaboration to investigate the cause of severe acute respiratory syndrome
K Stöhr
LANCET (2003)
Identification of severe acute respiratory syndrome in Canada
SM Poutanen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A major outbreak of severe acute respiratory syndrome in Hong Kong
N Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)
WH Seto et al.
LANCET (2003)
Coronavirus as a possible cause of severe acute respiratory syndrome
JSM Peiris et al.
LANCET (2003)
An outbreak of coronavirus OC43 respiratory infection in Normandy, France
A Vabret et al.
CLINICAL INFECTIOUS DISEASES (2003)
Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study
A Gagneur et al.
JOURNAL OF HOSPITAL INFECTION (2002)
Rhinovirus and coronavirus infection-associated hospitalizations among older adults
AR Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Neuroinvasion by human respiratory coronaviruses
N Arbour et al.
JOURNAL OF VIROLOGY (2000)
Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections
J Sizun et al.
JOURNAL OF HOSPITAL INFECTION (2000)
分享论文
